iFyber

is a contract research and development organization in the Information Technology industry, founded in 2009. The company's slogan "Creatively solving problems with science" reflects its focus on innovation and problem-solving. By offering development and testing services to the medical device, pharma, and consumer product industries, iFyber showcases its expertise in biocompatibility, antimicrobial, novel coating, small molecule, peptide, and protein applications. The most recent investment in iFyber was a $150.00K Grant received on 18 December 2012, with the National Science Foundation as the investor. This funding is indicative of the recognition and support the company has garnered from reputable entities within its field. iFyber's unique expertise at the interface of chemistry, biotechnology, and materials science enables the efficient advancement of innovations, indicating a promising trajectory for the company as it addresses untapped markets. In summary, iFyber's specialized services and targeted approach to research and development position the company as an intriguing prospect for venture capital investment, especially considering its recent backing from the National Science Foundation.